Veterinary Medicines Information website

Biocan DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live

Product identification

Medicine name:
Biocan DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDV Bio 11/A, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    4000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parvovirus, strain CPV-Bio 12, Live
    31623.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/01/1332
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 26/03/2026